We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Tempus ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s share price traded down 0% during mid-day trading on Thursday after an insider sold shares in the company. The stock traded as low as $47.12 and last ...

Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Monday reported a loss of $13 million in its fourth quarter. The Chicago-based company said it had a loss of 8 cents per share.

Seven board members and company insiders dumped a total of $4.3 million worth of Nancy Pelosi's latest stock holding, Tempus ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...

Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief ...